MDPI Books
Go to cart
Reprint
Download Flyer

<em>Helicobacter pylori </em> Infection and Related Diseases: Clinical Updates and Perspectives

Edited by
December 2023
138 pages
  • ISBN978-3-0365-9554-2 (Hardback)
  • ISBN978-3-0365-9555-9 (PDF)
https://doi.org/10.3390/books978-3-0365-9555-9
Free download (PDF)

This book is a reprint of the Special Issue Helicobacter pylori Infection and Related Diseases: Clinical Updates and Perspectives that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Helicobacter pylori is one of the most common infections in the world, affecting roughly half of all humans. Although it is not an infection that causes death immediately after infection, it is one of the largest emerging infectious diseases in the history of humankind, causing a wide variety of diseases and, in the long term, serious complications such as stomach cancer. This Reprint contains empirical studies and reviews regarding the diagnosis, treatment, complications, and management of H. pylori infection, including new diagnostic methods, effective eradication regimens, the management of gastric cancer, and other topics.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
gastric cancer; biliopancreatic reflux; gastritis; carcinoma; endoscopic surveillance; Helicobacter pylori infection; gastric stump cancer; Helicobacter pylori; H. pylori; rifabutin; treatment; eradication failure; culture; bismuth; rescue; Hp-EuReg; third-generation ultrathin endoscope; transnasal endoscopy; narrow-band imaging; Kyoto classification of gastritis; gastric atrophy and intestinal metaplasia; diagnosis; Helicobacter pylori; stool antigen test; urea breath test; Helicobacter pylori; gastric cancer; peptic ulcer disease; triple therapy; bismuth; vonoprazan; dyspepsia; Helicobacter pylori; Kyoto Classification of Gastritis; cagA; Okinawa; endoscopic findings; Helicobacter infection; tetracycline; eradication; penicillin allergy; furazolidone; metronidazole; amoxicillin; child; gastritis; Helicobacter pylori; host genetic factor; iron deficiency anemia; iron demand; iron uptake; sports activity; virulence factor; gastric lymphoma; MALT lymphoma; Helicobacter pylori; radiotherapy; chemotherapy; rituximab; H. pylori; dual therapy; vonoprazan (VPZ); amoxicillin (AMOX); clarithromycin (CAM)